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Background: Pemphigus Vulgaris is an autoimmune disease attacking the skin 
and mucous membranes. This disease is considered a rare disease. Epidemio-
logical data for Pemphigus Vulgaris in Indonesia remains limited, correspond-
ingly, nursing management in this disease. This study aims to describe nursing 
management in patients with Pemphigus Vulgaris. 
Case presentation: a case of Pemphigus Vulgaris in a 28-year-old male was 
reported, with complaints of blisters all over his body appearing since 2019 and 
have not been completely recovered at the Banyumas General Hospital, Central 
Java, Indonesia. 
Conclusion: A combination of wound care, nutrition, vitamins, and pharmacol-
ogy can accelerate the recovery of patients with Pemphigus Vulgaris. 
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The number of cases of Pemphigus Vulgaris worldwide 
has an incidence that varies from 0.5 to 3.2 cases per 
100,000 population with a mortality rate of 5-15%. Mortal-
ity in patients with Pemphigus Vulgaris is three times 
higher compared to the general population.1 Epidemiolog-
ical data for Pemphigus Vulgaris in Indonesia are still lim-
ited. The prevalence of this disease in Indonesia is 1-4 
cases per 100,000 people, with mortality reaching 75%.2 
There were five patients with Pemphigus Vulgaris cases at 
the Banyumas General Hospital in January 2020 - Decem-
ber 2020.3 
 
Up to the present time, research and data discussing the 
management of Pemphigus Vulgaris patients remain lim-
ited. The management mechanism of nursing manage-
ment in this disease has not been widely discussed. This 
study reports on the prevalence of Pemphigus Vulgaris in 
a male patient and describes the nursing management of 
patients with Pemphigus Vulgaris from various literature. 
CASE PRESENTATION 
A 28-year-old male came to the Hospital Emergency Unit 
complaining of blisters all over his body and oral area. The 
patient said that the wound was burning, itchy and painful. 
Based on the anamnesis results, the patient said that 
these symptoms had appeared since 2019 and had been 
treated at several hospitals. Nevertheless, the wound had 
never fully recovered. The patient denied a history of drug 
and food allergies. The general condition of the patient 
was pretty fit. Compos mentis consciousness, blood pres-
sure 120/70 mmHg, pulse 80 times/minute, temperature 
370 C, respiration 20 times/minute.  
 
The results of the wound assessment indicated that there 
were multiple erythematous macules, bullae, erosions all 
over the body with blackish-brown crusts, generalized dis-
tribution was in irregular shape, solid edges, and uneven 
surface. Sizes varied from 3x4 cm to 10x10 cm, and there 
was a solitary spherical erosion with a diameter of 3 cm 
covered with blackish-brown crusts (Fig. 1.A,B,C,D). The 
result of the Nikolsky signs physical examination on the 
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patient was positive. Based on the history and physical ex-
amination, and laboratory blood tests, the doctor diag-
nosed this patient with Pemphigus Vulgaris. 
 
The patient was treated with daily wound care and admin-
istration of silver sulfadiazine ointment to prevent skin in-
fection. Patients were provided with high calories and pro-
tein diet to help accelerate wound healing. Doctors also 
provided corticosteroid drug therapy, antibiotics, vitamin 
C, antihistamines, and adjuvant therapy to reduce the side 
effects of corticosteroid medication. After 21 days of treat-
ment, the wound appeared to be healing, and the tissue 
damage began to decrease, as shown in Figure 
2.A,B,C,D. 
 
A. Blister on chest are B. Blister on back area C. Blister on facial area 
 
D. Blister in oral area 
Figure 1. The Symptoms of Pemphigus Vulgaris 
 
A. Wound healing on chest 
area  
 
B. Wound healing on back 
area 
 
C. Wound healing on facial 
area 
 
D. Wound healing in oral area 
Figure 2. Wounds After 21 Days of Treatment 
 
DISCUSSION  
Pemphigus is an autoimmune disorder characterized by 
blisters on the skin and oral area. The wounds are formed 
due to acantholysis (separation of intra-cell cells) in the 
epidermis, which clinically appears as bullae. Acantholysis 
of pemphigus Vulgaris occurs in the sub-basal, particularly 
in the stratum spinosum or stratum granulosum and oral 
lesions. 4–7 Up to now, the exact cause of Pemphigus Vul-
garis is unknown. However, the disorder is associated with 
impaired immune regulation that produces autoantibodies 
that attack cell junctions (desmosomes) responsible for 
adhesion to other cells in cell tissue. 8–10. 
 
Risk factors that can increase or worsen pemphigus Vul-
garis include genetic factors (human leukocyte antigen 
DRw6 and human leukocyte antigen RD4, which are as-
sociated with major histocompatibility complex II mole-
cules), environmental factors such as ultraviolet radiation, 
autoimmune diseases (such as myasthenia gravis and 
thymoma) and the use of drugs such as D-Penicillamine 
and Captopril. 8,9,11,12 In this case, the exact cause of Pem-
phigus Vulgaris suffered by the patient is not yet known, 
and the symptoms first appeared in 2019 and have never 
fully recovered. The patient also had no history of drug or 
food allergies. 
 
The clinical depiction of pemphigus Vulgaris is character-
ized by erosions/blisters on the skin and mucosal layers. 
Wounds can also affect the skin all over the body.6,7 In 
about 60% of cases, the lesions/wounds first appear in the 
oral area; the remainder appears first on the scalp, face, 
neck, armpits, or genitals. Characteristics of the lesion are 
usually not itchy but painful. Bullae/blisters that rupture will 
form erosion and then crusting. This is a way for secondary 
infections that can increase mortality.13,14 In this case, the 
symptoms of blisters in the mouth and all over the body 
feel burning, itchy, painful, they have been treated in many 
hospitals, but the wound has never recovered completely. 
 
The diagnosis of pemphigus Vulgaris can be established if 
positive results are found on clinical examination, histolog-
ical examination, and immunologic tests.15 On the physical 
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examination, there is a Nikolsky sign, this sign can be seen 
by rubbing the hands from the normal area to the lesion, 
positive results appeared when there is peeling of the skin 
layer that indicates the shedding of the superficial layer of 
the basal layer of the epidermis. In addition, there is an 
Asboe-Hansen sign in the form of a bulla that widens when 
the middle part is pressed.13 Histological depiction of pem-
phigus Vulgaris is a suprabasal bulla with acantholysis. 
Sometimes it is seen that keratinocytes are released into 
the bulla, and the superficial parts of the epidermis are 
seen intact.16  
 
Immunological examination plays an important role, in-
cluding examining serum antibodies and skin lesions; an-
tibody examination of lesions is more specific and sensi-
tive than serum antibodies. Antibody testing also helps as-
sess the success of therapy. Serological examination of 
Enzyme-linked immunosorbent assay (ELISA) test to de-
termine the presence of antibodies that attack desmoglein 
1 and desmoglein 3 can also support the diagnosis of pem-
phigus Vulgaris.17 In this case, the diagnosis of pemphigus 
Vulgaris was established based on the clinical picture seen 
in the patient, namely blisters in the mouth and sores scat-
tered throughout the body. Nikolsky's physical examina-
tion results also indicated positive (+) results. In this case, 
no histologic, immunologic, or serological tests were per-
formed. 
 
In this case, the patient's wounds were treated every day; 
the patient was also given silver sulfadiazine ointment. The 
use of silver sulfadiazine ointment is suitable to help pre-
vent and treat infection in open wounds; this medication 
works by stopping the growth of bacteria in open 
wounds.18,19 The provision of a high-calorie diet, protein, 
and vitamin C was also carried out to help accelerate 
wound healing and increase the patient's immune system. 
The patient was also given immunosuppressant in the 
form of steroids. The use of corticosteroids was started 
with a high initial dose with a total injection dose of 
methylprednisolone 125 mg administered daily until clini-
cal symptoms improved. The corticosteroid dose would be 
reduced slowly to a maintenance dose of 40-50mg per day 
to avoid relapse. The administration of corticosteroid drugs 
was aimed to reduce inflammation. In this case, the treat-
ment was combined with antibiotics ceftriaxone injection 1 
gram per 12 hours and oral doxycycline 100 mg per 12 
hours in order to prevent secondary infection.4,20 
 
Corticosteroids have immunosuppressive solid and anti-
inflammatory effects that can cause high mortality and 
morbidity in patients. Therefore, to overcome the side ef-
fects of corticosteroids, it can be combined with adjuvant 
therapy (adjuvant corticosteroid-sparing) in the form of az-
athioprine, cyclosporine, methotrexate, and mycopheno-
late mofetil.4 In this case, the patient was also given meth-
otrexate (MTX). The dose given is 2x12.5 mg/week orally. 
Cetirizine therapy 1x10 mg was also given to patients to 
treat allergy symptoms and skin rashes.18  
 
In this case, a combination of the management of wound 
care, nutrition, and pharmacology in the form of cortico-
steroids, antibiotics, antihistamines, and adjuvant therapy 
(methotrexate) proved to be effective in relieving the pa-
tient's recovery. Although the treatment period in the hos-
pital took a longer time, which took 21 days, there was a 
very significant improvement in the patient's wounds. The 
wounds started to heal. It was seen that the condition of 
the wounds throughout the patient's body had recovered, 
and tissue damage had declined as well. 
CONCLUSIONS AND RECOMMENDATION 
Management of Pemphigus Vulgaris patients focuses on 
daily wound care, administration of silver sulfadiazine oint-
ment to prevent skin infections, and providing a high-calo-
rie and protein diet to support wound healing and pharma-
cological therapy as pharmacological therapy corticoster-
oids, antibiotics, vitamins and antihistamines, and therapy 
adjuvants. In this case, it was declared cured after 21 days 
of treatment, with signs of healing wound and decreased 
tissue damage. Standard operating procedures for man-
aging patients with Pemphigus Vulgaris need to be im-
proved so that patients' length of stay in the hospital can 
be shortened. 
REFERENCES 
1. Zeina B, Sakka N, Mansoor S. Pemphigus 
Vulgaris. Medscape. 2020. 
https://emedicine.medscape.com/article/1064187-
overview. 
2. Kurniawan F, Arisanty R. Karakteristik Klinik 
histopatologik dan Profil Imunofluoresensi Kasus 
Pemfigoid bulosa di Departemen Patologi 
Anatomik Rumah Sakit Cipto Mangunkusumo 
Tahun 2011-2018. Maj Patol Indones (The Indones 
J Pathol. 2020;29(3):139-144. 
3. RSUD Banyumas. Medical Record. Banyumas; 
2021. 
4. Porro AM, Hans Filho G, Santi CG. Consensus on 
the treatment of autoimmune bullous dermatoses: 
pemphigus vulgaris and pemphigus foliaceus - 
Brazilian Society of Dermatology. An Bras 
Dermatol. 2019;94(2 Suppl 1):20-32. 
doi:10.1590/abd1806-4841.2019940206 
5. Cholera M, Chainani-Wu N. Management of 
Pemphigus Vulgaris. Adv Ther. 2016;33(6):910-
958. doi:10.1007/s12325-016-0343-4 
6. Moraes da Silva A de F, Bernabé DG, Miyahara GI, 
Biasoli ER, Callestini R, Tjioe KC. Pemphigus 
Vulgaris: How to Perform an Oral Biopsy Properly? 




WIDI RAHMANINGSIH / MEDISAINS - VOL. 19 NO. 2 (2021) 56-59 
59 
7. Kuriachan D, Suresh R, Janardhanan M, Savithri 
V. Oral Lesions: The Clue to Diagnosis of 
Pemphigus Vulgaris. Case Rep Dent. 
2015;2015:593940. doi:10.1155/2015/593940 
8. Hammers CM, Stanley JR. Mechanisms of 
Disease: Pemphigus and Bullous Pemphigoid. 
Annu Rev Pathol. 2016;11:175-197. 
doi:10.1146/annurev-pathol-012615-044313 
9. Meyerle JH, Anhalt GJ. Pemphigus. BMJ Best 
Practice. https://bestpractice.bmj.com/topics/en-
us/454. Published 2021. 
10. Tamgadge S, Tamgadge A, Bhatt D, Bhalerao S, 
Pereira T. Pemphigus vulgaris. Contemp Clin Dent. 
2011;2(2):134-137. doi:10.4103/0976-237X.83074 
11. Ingold CJ, Khan MA. Pemphigus Vulgaris. 
Treasure Island (FL): StatPearls Publishing; 2021. 
12. Hertl M, Sitaru C. Pathogenesis, clinical 




pemphigus#H460257. Published 2021. 
13. James WD, Berger TG, Elston DM, Odom RB. 
Andrews’ Diseases of the Skin : Clinical 
Dermatology. 11th ed. Philadelphia: Saunders 
Elsevier; 2011. 
14. Bharathi U, Lingaraju N, Basappa S, MaheshM. S. 
Oral Pemphigus Vulgaris: A Case Report and 
Review. IOSR J Dent Med Sci. 2014;13:24-29. 
15. Singh S. Evidence-based treatments for 
pemphigus vulgaris, pemphigus foliaceus, and 
bullous  pemphigoid: a systematic review. Indian J 
Dermatol Venereol Leprol. 2011;77(4):456-469. 
doi:10.4103/0378-6323.82400 
16. Payne AS, Stanley JR. Pemphigus. In: Fitzpatrick’s 
Dermatology in General Medicine, 8e. New York: 
Mc Graw Hill; 2012. 
17. Bystryn J-C, Rudolph JL. Pemphigus. Lancet 
(London, England). 2005;366(9479):61-73. 
doi:10.1016/S0140-6736(05)66829-8 
18. Abedini R, Mahmoudi H, Kordestani S, Habib FN, 
Abyaneh M, Rahemi H. Comparison of topical 
nanocolloidal silver formulation use with eosin 2% 
solution in management of hard-to-heal ulcers in 
patients with pemphigus vulgaris. J Wound Care. 
2020;29(11):664-668. 
doi:10.12968/jowc.2020.29.11.664 
19. Soheila K, Farzaneh NH, Hosein SM. A Novel 
Wound Rinsing Solution Based On Nano Colloidal 
Silver. Nanomedicine J. 2014;1(5):315-323. 
https://www.sid.ir/en/journal/ViewPaper.aspx?id=4
12079. 
20. Rezeki S, Setyawati T. Pemphigus Vulgaris: 
Pentingnya Diagnosis Dini, Penatalaksanaan Yang 
Komprehensif Dan Adekuat (Laporan Kasus). 
Indones J Dent. 2009;16(1):1-7. 
doi:10.14693/jdi.v16i1.20 
 
